Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease

ABSTRACT Pompe disease (PD) is a potentially lethal illness involving irreversible muscle damage resulting from glycogen storage in muscle fiber and activation of autophagic pathways. A promising therapeutic perspective for PD is enzyme replacement therapy (ERT) with the human recombinant enzyme aci...

Full description

Bibliographic Details
Main Authors: Juan Clinton Llerena Junior, Osvaldo JM Nascimento, Acary Souza B Oliveira, Mario Emilio T Dourado Junior, Carlo D Marrone, Heloise Helena Siqueira, Cláudia F R Sobreira, Elza Dias-Tosta, Lineu Cesar Werneck
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2015-01-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015005011103&lng=en&tlng=en
_version_ 1818546405498683392
author Juan Clinton Llerena Junior
Osvaldo JM Nascimento
Acary Souza B Oliveira
Mario Emilio T Dourado Junior
Carlo D Marrone
Heloise Helena Siqueira
Cláudia F R Sobreira
Elza Dias-Tosta
Lineu Cesar Werneck
author_facet Juan Clinton Llerena Junior
Osvaldo JM Nascimento
Acary Souza B Oliveira
Mario Emilio T Dourado Junior
Carlo D Marrone
Heloise Helena Siqueira
Cláudia F R Sobreira
Elza Dias-Tosta
Lineu Cesar Werneck
author_sort Juan Clinton Llerena Junior
collection DOAJ
description ABSTRACT Pompe disease (PD) is a potentially lethal illness involving irreversible muscle damage resulting from glycogen storage in muscle fiber and activation of autophagic pathways. A promising therapeutic perspective for PD is enzyme replacement therapy (ERT) with the human recombinant enzyme acid alpha-glucosidase (Myozyme®). The need to organize a diagnostic flowchart, systematize clinical follow-up, and establish new therapeutic recommendations has become vital, as ERT ensures greater patient longevity. A task force of experienced clinicians outlined a protocol for diagnosis, monitoring, treatment, genetic counseling, and rehabilitation for PD patients. The study was conducted under the coordination of REBREPOM, the Brazilian Network for Studies of PD. The meeting of these experts took place in October 2013, at L’Hotel Port Bay in São Paulo, Brazil. In August 2014, the text was reassessed and updated. Given the rarity of PD and limited high-impact publications, experts submitted their views.
first_indexed 2024-12-12T07:52:46Z
format Article
id doaj.art-b05959189a28442e9799903a1f8264e6
institution Directory Open Access Journal
issn 1678-4227
language English
last_indexed 2024-12-12T07:52:46Z
publishDate 2015-01-01
publisher Academia Brasileira de Neurologia (ABNEURO)
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj.art-b05959189a28442e9799903a1f8264e62022-12-22T00:32:24ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-42272015-01-01010.1590/0004-282X20150194S0004-282X2015005011103Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe diseaseJuan Clinton Llerena JuniorOsvaldo JM NascimentoAcary Souza B OliveiraMario Emilio T Dourado JuniorCarlo D MarroneHeloise Helena SiqueiraCláudia F R SobreiraElza Dias-TostaLineu Cesar WerneckABSTRACT Pompe disease (PD) is a potentially lethal illness involving irreversible muscle damage resulting from glycogen storage in muscle fiber and activation of autophagic pathways. A promising therapeutic perspective for PD is enzyme replacement therapy (ERT) with the human recombinant enzyme acid alpha-glucosidase (Myozyme®). The need to organize a diagnostic flowchart, systematize clinical follow-up, and establish new therapeutic recommendations has become vital, as ERT ensures greater patient longevity. A task force of experienced clinicians outlined a protocol for diagnosis, monitoring, treatment, genetic counseling, and rehabilitation for PD patients. The study was conducted under the coordination of REBREPOM, the Brazilian Network for Studies of PD. The meeting of these experts took place in October 2013, at L’Hotel Port Bay in São Paulo, Brazil. In August 2014, the text was reassessed and updated. Given the rarity of PD and limited high-impact publications, experts submitted their views.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015005011103&lng=en&tlng=endoença de Pompe, doença de depósito de glicogênio tipo IIalfa-glicosidade ácidadebilidade musculardispneiagene GAAGAA recombinante humana
spellingShingle Juan Clinton Llerena Junior
Osvaldo JM Nascimento
Acary Souza B Oliveira
Mario Emilio T Dourado Junior
Carlo D Marrone
Heloise Helena Siqueira
Cláudia F R Sobreira
Elza Dias-Tosta
Lineu Cesar Werneck
Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
Arquivos de Neuro-Psiquiatria
doença de Pompe, doença de depósito de glicogênio tipo II
alfa-glicosidade ácida
debilidade muscular
dispneia
gene GAA
GAA recombinante humana
title Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
title_full Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
title_fullStr Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
title_full_unstemmed Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
title_short Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease
title_sort guidelines for the diagnosis treatment and clinical monitoring of patients with juvenile and adult pompe disease
topic doença de Pompe, doença de depósito de glicogênio tipo II
alfa-glicosidade ácida
debilidade muscular
dispneia
gene GAA
GAA recombinante humana
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015005011103&lng=en&tlng=en
work_keys_str_mv AT juanclintonllerenajunior guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT osvaldojmnascimento guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT acarysouzaboliveira guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT marioemiliotdouradojunior guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT carlodmarrone guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT heloisehelenasiqueira guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT claudiafrsobreira guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT elzadiastosta guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease
AT lineucesarwerneck guidelinesforthediagnosistreatmentandclinicalmonitoringofpatientswithjuvenileandadultpompedisease